SLC30A1 expression was increased and SLC39A8 decreased in MAC-MT cells in cancer compared to non-tumor samples (Figure 6B), the overall effect of which may be to increase zinc efflux, potentially counteracting the known decreased zinc concentration associated with prostate cancer. Here, SLC39A8 is linked to prostate carcinoma.